183 related articles for article (PubMed ID: 2697582)
1. Monoclonal and biclonal immunoglobulin-producing disorders.
Osterborg A; Mellstedt H
Eur J Haematol Suppl; 1989; 51():11-8. PubMed ID: 2697582
[TBL] [Abstract][Full Text] [Related]
2. [Monoclonal gammopathies of undetermined significance. Clinical course and biological aspects of 397 cases].
Giraldo MP; Rubio-Félix D; Perella M; Gracía JA; Bergua JM; Giralt M
Sangre (Barc); 1991 Oct; 36(5):377-82. PubMed ID: 1816635
[TBL] [Abstract][Full Text] [Related]
3. Pathogenetic relation between monoclonal gammopathies of undetermined significance and multiple myeloma.
Greipp PR; Lust JA
Stem Cells; 1995 Aug; 13 Suppl 2():10-21. PubMed ID: 8520496
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and outcomes in biclonal gammopathies.
Mullikin TC; Rajkumar SV; Dispenzieri A; Buadi FK; Lacy MQ; Lin Y; Dingli D; Go RS; Hayman SR; Zeldenrust SR; Russell SJ; Lust JA; Leung N; Kapoor P; Kyle RA; Gertz MA; Kumar SK
Am J Hematol; 2016 May; 91(5):473-5. PubMed ID: 26840395
[TBL] [Abstract][Full Text] [Related]
5. [Immunoglobulin heavy chain gene rearrangements in the monoclonal gammopathies].
Bosaleh A; Denninghoff V; Garcia A; Rescia C; Avagnina A; Elsner B
Medicina (B Aires); 2005; 65(3):219-25. PubMed ID: 16042132
[TBL] [Abstract][Full Text] [Related]
6. [Neurologic manifestations of monoclonal gammapathies].
Uldry PA; Steck AJ; Regli F
Schweiz Med Wochenschr; 1984 Nov; 114(47):1678-85. PubMed ID: 6096963
[TBL] [Abstract][Full Text] [Related]
7. Biclonal gammopathy in multiple myeloma: a case report.
Bakta IM; Sutarka IN
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():544-8. PubMed ID: 10895208
[TBL] [Abstract][Full Text] [Related]
8. The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance.
Gregersen H; Mellemkjaer L; Ibsen JS; Dahlerup JF; Thomassen L; Sørensen HT
Haematologica; 2001 Nov; 86(11):1172-9. PubMed ID: 11694403
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
[TBL] [Abstract][Full Text] [Related]
10. The incidence and epidemiology of plasma cell neoplasms.
Bergsagel D
Stem Cells; 1995 Aug; 13 Suppl 2():1-9. PubMed ID: 8520495
[TBL] [Abstract][Full Text] [Related]
11. [Biclonal gammopathies: clinical and theoretical aspects].
Cohen Y; Ben-Bassat I
Harefuah; 1993 Apr; 124(7):393-5, 456. PubMed ID: 8330781
[TBL] [Abstract][Full Text] [Related]
12. [Determination of lymphocyte subpopulations in multiple myeloma and monoclonal gammopathies of undetermined significance].
Luraschi A; Fedeli P; Rossi M; Montanara S; Perlasca S; Cozzi S
Minerva Med; 1986 Jun; 77(26):1235-41. PubMed ID: 3088491
[TBL] [Abstract][Full Text] [Related]
13. RAS mutations are uncommon in multiple myeloma and other monoclonal gammopathies.
Martín P; Santón A; García-Cosío M; Bellas C
Int J Oncol; 2005 Oct; 27(4):1023-8. PubMed ID: 16142319
[TBL] [Abstract][Full Text] [Related]
14. [The clinical significance of M proteins].
Sasaki R
Rinsho Byori; 2001 Jul; 49(7):678-81. PubMed ID: 11519130
[TBL] [Abstract][Full Text] [Related]
15. The relationship between proliferation and apoptosis in patients with monoclonal gammopathy of undetermined significance or multiple myeloma.
Scudla V; Ordeltova M; Bacovsky J; Vytrasova M; Horak P; Minarik J
Haematologica; 2005 Dec; 90(12):1713-4. PubMed ID: 16330455
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal gammopathy of undetermined significance.
Kyle RA; Rajkumar SV
Clin Lymphoma Myeloma; 2005 Sep; 6(2):102-14. PubMed ID: 16231848
[TBL] [Abstract][Full Text] [Related]
17. [Monoclonal gammopathies of undetermined significance].
Krizalkovicová V; Maisnar V; Pour L; Radocha J; Hájek R
Klin Onkol; 2008; 21(4):160-4. PubMed ID: 19102222
[TBL] [Abstract][Full Text] [Related]
18. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
Anagnostopoulos A; Evangelopoulou A; Sotou D; Gika D; Mitsibounas D; Dimopoulos MA
Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
[TBL] [Abstract][Full Text] [Related]
19. Familial monoclonal gammopathy: hyper-responsive B cells in unaffected family members.
Steingrímsdóttir H; Einarsdóttir HK; Haraldsdóttir V; Ogmundsdóttir HM
Eur J Haematol; 2011 May; 86(5):396-404. PubMed ID: 21342269
[TBL] [Abstract][Full Text] [Related]
20. [Monoclonal gammapathies in Tunisia: epidemiological, immunochemical and etiological analysis of 288 cases].
Mseddi-Hdiji S; Haddouk S; Ben Ayed M; Tahri N; Elloumi M; Baklouti S; Hachicha J; Krichen MS; Bahloul Z; Masmoudi H
Pathol Biol (Paris); 2005 Feb; 53(1):19-25. PubMed ID: 15620605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
